학술논문

Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.
Document Type
Article
Source
Blood Cancer Journal; May2021, Vol. 11 Issue 5, p1-16, 16p
Subject
ACUTE myeloid leukemia
CANCER cells
GENE expression
CRISPRS
RUXOLITINIB
Language
ISSN
20445385
Abstract
Copyright of Blood Cancer Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)